67 related articles for article (PubMed ID: 28472813)
1. Expression and Significance of MTA2 and CPNE1 in Cervical Squamous Cell Carcinoma.
Wang L; Chen G; Zhou C; Wu C; Jiang J
Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):569-573. PubMed ID: 37399268
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Stromal Support Model for Predicting Human Papillomavirus-Associated Cancer Drug Responses.
James CD; Lewis RL; Fakunmoju AL; Witt AJ; Youssef AH; Wang X; Rais NM; Prabhakar AT; Otoa R; Bristol ML
bioRxiv; 2024 Apr; ():. PubMed ID: 38644998
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.
Spurgeon ME; den Boon JA; Horswill M; Barthakur S; Forouzan O; Rader JS; Beebe DJ; Roopra A; Ahlquist P; Lambert PF
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9076-E9085. PubMed ID: 29073104
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Downregulating Estrogen Receptor Alpha Expression in Cervical Cancer.
Yu P; Wang Y; Li C; Lv L; Wang J
Anticancer Agents Med Chem; 2018; 18(14):1975-1982. PubMed ID: 30173650
[TBL] [Abstract][Full Text] [Related]
5. The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.
Friese K; Kost B; Vattai A; Marmé F; Kuhn C; Mahner S; Dannecker C; Jeschke U; Heublein S
J Cancer Res Clin Oncol; 2018 Jan; 144(1):13-19. PubMed ID: 28924735
[TBL] [Abstract][Full Text] [Related]
6. Epithelial oestrogen receptor α is dispensable for the development of oestrogen-induced cervical neoplastic diseases.
Son J; Park Y; Chung SH
J Pathol; 2018 Jun; 245(2):147-152. PubMed ID: 29532467
[TBL] [Abstract][Full Text] [Related]
7. Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer.
Bartl T; Grimm C; Mader RM; Zielinski C; Prager G; Unseld M; Herac-Kornauth M
J Pers Med; 2023 Jul; 13(8):. PubMed ID: 37623437
[TBL] [Abstract][Full Text] [Related]
8. Novel biogenic silver nanoconjugates of Abrus precatorius seed extracts and their antiproliferative and antiangiogenic efficacies.
Kaur A; Sharma Y; Singh G; Kumar A; Kaushik N; Khan AA; Bala K
Sci Rep; 2023 Aug; 13(1):13514. PubMed ID: 37598190
[TBL] [Abstract][Full Text] [Related]
9. Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer.
Garrido F; Wild CM; Jeschke U; Dannecker C; Mayr D; Cavailles V; Mahner S; Kost B; Heidegger HH; Vattai A
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769131
[TBL] [Abstract][Full Text] [Related]
10. Combination of Estrogen Receptor Alpha and Histological Type Helps to Predict Lymph Node Metastasis in Patients with Stage IA2 to IIA2 Cervical Cancer.
Ke Y; Zu S; Chen L; Liu M; Yang H; Wang F; Zheng H; He F
Cancer Manag Res; 2022; 14():317-325. PubMed ID: 35115830
[TBL] [Abstract][Full Text] [Related]
11. Estrogen Inhibits Epithelial Progesterone Receptor-Dependent Progestin Therapy Efficacy in a Mouse Model of Cervical Cancer.
Baik S; Mehta FF; Unsal E; Park Y; Chung SH
Am J Pathol; 2022 Feb; 192(2):353-360. PubMed ID: 34774516
[TBL] [Abstract][Full Text] [Related]
12. WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7.
Kumagai K; Takanashi M; Ohno SI; Harada Y; Fujita K; Oikawa K; Sudo K; Ikeda SI; Nishi H; Oikawa K; Kuroda M
Oncogene; 2021 May; 40(21):3695-3706. PubMed ID: 33947962
[TBL] [Abstract][Full Text] [Related]
13. Progesterone Receptor Is a Haploinsufficient Tumor-Suppressor Gene in Cervical Cancer.
Park Y; Baik S; Ho C; Lin CY; Chung SH
Mol Cancer Res; 2021 Jan; 19(1):42-47. PubMed ID: 33139507
[TBL] [Abstract][Full Text] [Related]
14. Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment.
Cheng HS; Lee JXT; Wahli W; Tan NS
Mol Cancer; 2019 Mar; 18(1):51. PubMed ID: 30925918
[TBL] [Abstract][Full Text] [Related]
15. Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.
Hong MK; Wang JH; Su CC; Li MH; Hsu YH; Chu TY
Int J Gynecol Cancer; 2017 Jul; 27(6):1247-1255. PubMed ID: 28472813
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas.
Kwasniewska A; Postawski K; Gozdzicka-Jozefiak A; Kwasniewski W; Grywalska E; Zdunek M; Korobowicz E
Oncol Rep; 2011 Jul; 26(1):153-60. PubMed ID: 21491087
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
